Skip to content
Valicare – Your GMP Partner
Valicare – Your GMP Partner
Together more successful!

Your GMP service provider for pharma, biotech & cell and gene therapy

Are you looking for comprehensive GMP services? Then Valicare is your ideal point of contact. We have been providing a broad range of classical and specialized GMP services to the pharmaceutical, biotechnology, cell and gene therapy industries for more than 20 years.

Valicare is a 100% subsidiary of Syntegon. Our headquarters are based in Frankfurt (Main), Germany, and our sister company in Trenčín, Slovakia. Our broad GMP consulting, qualification and validation portfolio is the ideal complement to Syntegon's seamless single-source pharmaceutical line solutions and those of other providers. Whether you need support in ensuring GMP-compliance, services for cell and gene therapies, risk-based qualification and validation support or Computerized System Validation, CSV: Valicare offers the expertise and experience you need to ensure the successful completion of your projects.

Your benefits

  • Seamless solutions from a single source in collaboration with Syntegon
  • Risk-based and integrated qualification and validation of your processes – from GMP consultation to implementation
  • Time and resource savings by entrusting your qualification and validation projects to our highly qualified GMP experts
  • Short project lead times thanks to efficient planning and execution
  • Faster market introduction of your new products

Our services

More than 5,000 successfully completed projects all over the world speak for themselves. Valicare is your partner for everything GMP-related. Our senior consultants have been working in the GMP-regulated environment for more than 20 years. They are always up to date with European and international regulations. Moreover, our highly experienced validation experts have a comprehensive technical understanding of process and packaging technology.

Find out more:

GMP Compliance

GMP Compliance

Qualification & Validation

Qualification & Validation

GMP for Cell and Gene Therapy

GMP for Cell and Gene Therapy

Isolator Technology

Isolator Technology

Kein Titel (1123 x 650 px)

SoHO Regulation 2024/1938

Overview of the SoHO Regulation (EU) 2024/1938, which will apply from August 7, 2027. Requirements and solution approaches provided by Valicare.

Our business areas

Our business areas are as diverse as our expertise. We serve the pharmaceutical and biopharmaceutical industry with GMP consulting and qualification and validation services. At the same time, we offer specialized support for cell and gene therapies. What all these areas have in common is the need for sustainable and reliable support from a single source. Valicare is here to provide that support.

 

Over
years of experience
More than
projects per year
Over
employees
background-image

This speaks for a cooperation with us:

Minimizing production risk

Minimizing production risk

Extensive experience with pharmaceutical manufacturing requirements

Advance planning and cost forecasting

Advance planning and cost forecasting

Immediate setup of manufacturing and quality control concepts

Simplifying complex processes

Simplifying complex processes

Extensive expertise regarding the requirements for an optimized pharmaceutical quality management system (PQM)

News

14th GSCN Conference The 14th GSCN Conference will take place from September 9 to 11, 2026, at the Max Delbrück Center.
ATMP Block Lecture 2026

Learn more about the 2026 virtual ATMP block lecture.

Webinar: Continuous Process Verification (CPV) in GMP

Learn more about our webinar on computer system validation (CSV) and computer software assurance...

Webinar: CSV versus CSA

Find out more about our webinar on computerized system validation (CSV) and computer software...

Frankfurt am Main, Germany

Frankfurt am Main, Germany

Valicare GmbH

Eschborner Landstraße 130-132
60489 Frankfurt am Main
Germany

Opening hours:
Monday - Friday 08:00 - 16:00 

Phone: +49 69 153 293 700
Email: info@valicare.com

Contact us